KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Other Accumulated Expenses (2017 - 2025)

Historic Other Accumulated Expenses for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $665.0 million.

  • Elanco Animal Health's Other Accumulated Expenses fell 291.97% to $665.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $665.0 million, marking a year-over-year decrease of 291.97%. This contributed to the annual value of $643.0 million for FY2024, which is 5721.27% up from last year.
  • Per Elanco Animal Health's latest filing, its Other Accumulated Expenses stood at $665.0 million for Q3 2025, which was down 291.97% from $596.0 million recorded in Q2 2025.
  • In the past 5 years, Elanco Animal Health's Other Accumulated Expenses registered a high of $685.0 million during Q3 2024, and its lowest value of $377.0 million during Q1 2023.
  • Moreover, its 5-year median value for Other Accumulated Expenses was $510.0 million (2024), whereas its average is $520.6 million.
  • Over the last 5 years, Elanco Animal Health's Other Accumulated Expenses had its largest YoY gain of 16332.72% in 2021, and its largest YoY loss of 2667.79% in 2021.
  • Over the past 5 years, Elanco Animal Health's Other Accumulated Expenses (Quarter) stood at $433.0 million in 2021, then increased by 4.85% to $454.0 million in 2022, then dropped by 9.91% to $409.0 million in 2023, then skyrocketed by 57.21% to $643.0 million in 2024, then increased by 3.42% to $665.0 million in 2025.
  • Its Other Accumulated Expenses stands at $665.0 million for Q3 2025, versus $596.0 million for Q2 2025 and $576.0 million for Q1 2025.